Post-IPO Debt - Theratechnologies

Post-IPO Debt - Theratechnologies

Investment Firm

Overview

Theratechnologies is a a bio-pharmaceutical company, engages in the discovery of therapeutic products for commercialisation.

Announced Date

Jul 27, 2022

Funding Type

Post Ipo Debt

Highlights

Location

North America

Social

Investor Lead

Marathon Asset Management

Marathon Asset Management

No designation

Participant Investors

1

Investor Name
Participant InvestorMarathon Asset Management

Round Details and Background

Theratechnologies raised $60000000 on 2022-07-27 in Post-IPO Debt

Theratechnologies is a a bio-pharmaceutical company, engages in the discovery of therapeutic products for commercialisation.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 19, 2021
Post-IPO Equity - Theratechnologies
-46.2M
Jun 19, 2018
Post-IPO Debt - Theratechnologies
-57.5M
Nov 14, 2016
Post-IPO Equity - Theratechnologies
-12.2M
Aug 06, 2015
Post-IPO Equity - Theratechnologies
-11.0M

Recent Activity

There is no recent news or activity for this profile.